Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation


Autoria(s): TAMANAHA, Rosana; CAMACHO, Cleber P.; PEREIRA, Alexandre C.; SILVA, Adriana M. Alvares da; MACIEL, Rui M. B.; CERUTTI, Janete M.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

P>Context We previously described a six-generation family with G533C RET mutation and medullary thyroid carcinoma, in the largest family reported do date. Of particular interest, phenotype variability regarding the age of onset and clinical presentation of the disease, was observed. Objective We evaluate whether single SNPs within RET oncogene or haplotype comprising the RET variants (defined by Haploview) could predispose to early development of MTC in this family and influence the clinical manifestation. Design Eight SNPs were selected based on their previous association with the clinical course of hereditary or sporadic MTC, in particular promoting an early onset of disease. The variants were initially tested in 77 G533C-carriers and 100 controls using either PCR-direct sequencing or PCR-RFLP. Association between a SNP or haplotype and age at diagnosis or presence of lymph node metastasis was tested in 34 G533C-carries with MTC. Different bioinformatic tools were used to evaluate the potential effects on RNA splicing. Results An association was found between IVS1-126G > T and age at diagnosis. The variant [IVS8 +82A > G; 85-86 insC] was associated with the presence of lymph node metastases at diagnosis. In silico analysis suggested that this variant may induce abnormal splicing. This in silico analysis predicted that the [IVS8 +82A > G; 85-86 insC] could alter the splicing by disrupting and/or creating exonic splicing enhancer motifs. Conclusions We here identified two RET variants that were associated with phenotype variability in G533C-carriers, which highlights the fact that the modifier effect of a variant might depend on the type of mutation.

Sao Paulo State Research Foundation (FAPESP)[04/15288-0]

Sao Paulo State Research Foundation (FAPESP)[05/60330-8]

Sao Paulo State Research Foundation (FAPESP)[06/60402-1]

Brazilian Research Council (CNPq)

CAPES

Identificador

CLINICAL ENDOCRINOLOGY, v.71, n.1, p.56-64, 2009

0300-0664

http://producao.usp.br/handle/BDPI/23266

10.1111/j.1365-2265.2008.03491.x

http://dx.doi.org/10.1111/j.1365-2265.2008.03491.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

Clinical Endocrinology

Direitos

closedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #MEDULLARY-THYROID CARCINOMA #DEHYDROGENASE MESSENGER-RNA #ENDOCRINE NEOPLASIA TYPE-2 #CODON 918 MUTATION #HIRSCHSPRUNG-DISEASE #GENETIC MODIFIERS #MENTAL-RETARDATION #GENERAL-POPULATION #SEQUENCE VARIANT #LACTIC-ACIDOSIS #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion